1.Yassin, SF, Young-Fadok, TM, Zein, NN, Pardi, DS. Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc 2001;76:725–730.
2.Archibald, LK, Banerjee, SN, Jarvis, WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585–1589.
3.Thomas, C, Stevenson, M, Williamson, DJ, Riley, TV. Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy. Clin Infect Dis 2002;35:1457–1462.
4.McDonald, LC, Killgore, GE, Thompson, A, et al.An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433–2441.
5.Kazakova, SV, Ware, K, Baughman, B, et al.A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006;166:2518–2524.
6.Hubert, B, Loo, VG, Bourgault, AM, et al.A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007;44:238–244.
7.Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr.Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.
8.Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40:1–15.
9.Kyne, L, Sougioultzis, S, McFarland, LV, Kelly, CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002;23:653–659.
10.McFarland, LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292–307.
11.Thomas, C, Stevenson, M, Riley, TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003;51:1339–1350.
12.McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized Patients. J Infect Dis 1990;162:678–684.
13.Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989–2995.
14.Bartlett, JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006;145:758–764.
15.Climo, MW, Israel, DS, Wong, ES, Williams, D, Coudron, P, Markowitz, SM. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998;128:989–995.
16.Pepin, J, Saheb, N, Coulombe, MA, et al.Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrheas cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254–1260.
17.Modena, S, Bearelly, D, Swartz, K, Friedenberg, FK. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol 2005;26:685–690.
18.Palmore, TN, Sohn, S, Malak, SE, Eagan, J, Sepkowitz, KA. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 2005;26:680–684.
19.McCusker, ME, Harris, AD, Perencevich, E, Roghmann, MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003;9:730–733.
20.Anand, A, Bashey, B, Mir, T, Glatt, AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994;89:519–523.
21.Gaynes, R, Rimland, D, Killum, E, et al.Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004;38:640–645.
22.Zimmerman, RK. Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission. Infect Control Hosp Epidemiol 1991;12:96–100.
23.Dhalla, IA, Mamdani, MM, Simor, AE, Kopp, A, Rochon, PA, Juurlink, DN. Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease? Antimicrob Agents Chemother 2006;50:3216–3219.
24.Raveh, D, Rabinowitz, B, Breuer, GS, Rudensky, B, Yinnon, AM. Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea. Int J Antimicrob Agents 2006;28:231–237.
25.Wistrom, J, Norrby, SR, Myhre, EB, et al.Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001;47:43–50.
26.Chang, VT, Nelson, K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000;31:717–722.
27.Starr, JM, Martin, H, McCoubrey, J, Gibson, G, Poxton, IR. Risk factors for Clostridium difficile colonisation and toxin production. Age Ageing 2003;32:657–660.
28.Muto, CA, Pokrywka, M, Shutt, K, et al.A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273–280.
29.Ray, GT, Levine, P, Croen, LA, Bokhari, FA, Hu, TW, Habel, LA. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch Pediatr Adolesc Med 2006;160:1063–1069.
30.Ray, GT, Mertens, JR, Weisner, C. The excess medical cost and health problems of family members of persons diagnosed with alcohol or drug problems. Med Care 2007;45:116–122.
31.Vesta, KS, Wells, PG, Gentry, CA, Stipek, WJ. Specific risk factors for Clostridium difficile-associated diarrhea: A prospective, multicenter, case control evaluation. Am J Infect Control 2005;33:469–472.
32.Changela, U, Cannon, JP, Aneziokoro, C, Shah, PS, Thottapurathu, L, Len-tino, J. Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital. Int J Antimicrob Agents 2004;24:562–566.
33.Loo, VG, Poirier, L, Miller, MA, et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.
34.Gerding, DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004;38:646–648.
35.Johnson, S, Samore, MH, Farrow, KA, et al.Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999;341:1645–1651.